Answer of the Day for Nov 28, 2022
NOVEMBER 27, 2022
Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? Yes. The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components.
Let's personalize your content